[Implantable loop recorders for prolonged heart-rhythm monitoring in patients with cryptogenic stroke]

O A Nikolaeva1, O V Sapelnikov1, I R Grishin1

  • 1Russian Cardiology Research Center, Moscow, Russia.

Insights

Implantable loop recorders (ILR) effectively diagnose atrial fibrillation (AF) in patients with cardiac embolism. This technology aids in timely arrhythmia detection and subsequent treatment initiation.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Cardiac embolism, often following stroke or transient ischemic attack, poses a significant risk.
  • Atrial fibrillation (AF) is a common cause of cardioembolic stroke.
  • Early detection of AF is crucial for preventing recurrent cerebrovascular events.

Purpose of the Study:

  • To evaluate the efficacy of implantable loop recorders (ILR) for the timely diagnosis of atrial fibrillation (AF) in patients with a history of cardiac embolism.
  • To assess the diagnostic yield and management implications of ILR monitoring in this high-risk population.

Main Methods:

  • A prospective study involving 29 patients hospitalized within six months of stroke or transient ischemic attack.
  • Implantation of ILR in all participants for continuous cardiac rhythm monitoring.
  • A mean follow-up period of one year with analysis of recorded transmissions.

Main Results:

  • Continuous monitoring detected arrhythmias in 5 patients, including 3 cases of atrial fibrillation.
  • A total of 513 transmissions were recorded, with symptomatic episodes in 165 cases.
  • Despite some false-positive over-sensing events, ILR facilitated the diagnosis of significant arrhythmias, leading to immediate anticoagulant therapy initiation in AF patients.

Conclusions:

  • Loop recording monitoring using ILR is an effective strategy for the timely diagnosis of arrhythmias, particularly atrial fibrillation, in patients with cardiac embolism.
  • Early diagnosis through ILR enables prompt initiation of appropriate anticoagulant therapy, potentially reducing the risk of future embolic events.
Abstract